Blockade of the FGL1/LAG3 axis with concurrent administration of metformin can enhance T-cell-mediated immune response, improve the tumor microenvironment immunosuppression, and enhance general anti-tumor immunity 46. The gene discussed is FGL1; the disease is neoplasm.